BPG is committed to discovery and dissemination of knowledge
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Bhatia J, Gamad N, Bharti S, Arya DS. Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data. World J Diabetes 2014; 5(3): 399-406 [PMID: 24936262 DOI: 10.4239/wjd.v5.i3.399]
Corresponding Author of This Article
Dr. Jagriti Bhatia, Department of Pharmacology, All India Institute of Medical Sciences, Gautam Nagar, New Delhi-110029, India. jagriti2012@gmail.com
Research Domain of This Article
Pharmacology & Pharmacy
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6441)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2014 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Total Visits of This Article
2019 | Number of total visits
Rank | Countries/Territories | Count | Percent |
1 | 29 | 100% |